Drug
13 Valent Pneumococcal Conjugate Vaccine
13 Valent Pneumococcal Conjugate Vaccine: highest development phase Phase 3, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| 13-valent Pneumococcal Conjugate Vaccine NCT00368966 | Phase 3 | Vaccines, Pneumococcal |
Latest
No recent events.
Follow 13 Valent Pneumococcal Conjugate Vaccine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.